Related Experiment Videos

Diabetic vascular disease and smoking

P Hollander, J P Palmer

American Family Physician

|July 1, 1980

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Altered profile of immune regulatory cells in the peripheral blood of lymphoma patients.

BMC cancer·2019

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials.

Diabetes, obesity & metabolism·2015

Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies.

Genes and immunity·2015

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus.

Diabetes, obesity & metabolism·2015

Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study).

Diabetes, obesity & metabolism·2015

Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy.

Diabetes, obesity & metabolism·2014

See all related articles